Last Updated: September 25, 2026

Drug Sales Trends for torsemide


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for torsemide (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $3,861,969
INSIDE ANOTHER STORE $17,390,769
[disabled in preview] $18,420,831
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 262,315
INSIDE ANOTHER STORE 645,078
[disabled in preview] 1,209,799
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $1,797,215
MEDICARE $19,924,328
[disabled in preview] $17,952,027
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for torsemide
Drug Units Sold Trends for torsemide

Annual Sales Revenues and Units Sold for torsemide

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2022
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2021
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2020
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2019
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2018
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2017
TORSEMIDE ⤷  Start Trial ⤷  Start Trial 2016
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.